Bendamustine( SDX105 )

Catalog No. M21612 CAS No. 16506-27-7

Bendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	82	In Stock
2MG	43	In Stock
5MG	68	In Stock
10MG	116	In Stock
25MG	258	In Stock
50MG	398	In Stock
100MG	594	In Stock
200MG	Get Quote	In Stock
500MG	1274	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Bendamustine
Note

Research use only, not for human use.
Brief Description

Bendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
Description

Bendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
In Vitro

——
In Vivo

——
Synonyms

SDX105
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

cancer
Indication

Hodgkin's Disease Lymphoma

Chemical Information

CAS Number

16506-27-7
Formula Weight

358.26
Molecular Formula

C16H21Cl2N3O2
Purity

>98% (HPLC)
Solubility

DMSO:72 mg/mL (200.97 mM)
SMILES

Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Patekar M B Milunovi V Jakobac K M et al. Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia[J]. Acta Clinica Croatica 2018 57(3):542-553.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

Product			Quantity Required*
Name *			E-mail Address *
Organization *			Phone Number
Remarks